SUMMARY The incidence of ascorbic acid (AA) deficiency and its effect on serum ferritin concentration relative to body iron stores was studied in 61 unchelated patients with /-thalassaemia major.
Ascorbic acid deficiency (AA) causes major abnormalities in iron metabolism in man, including an inappropriately low serum iron concentration in relation to tissue iron stores.' Ascorbic acid deficiency and frank scurvy commonly occur in Bantu patients with dietary iron overload,2 and has also been reported in primary haemochromatosis and in transfusional iron overload.3
There have been few reports in man on the effect of AA deficiency on serum ferritin concentrations although AA is involved in the incorporation and release of iron from ferritin and in the removal of iron from haemosiderin.4 5 Serum ferritin concentration is directly related to body iron stores in normal human subjects, 6 and has proved to be useful in the diagnosis of iron overload and in monitoring response to therapy.7 8 However, raised concentrations of serum ferritin
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Accepted for publication 2 September 1981 are found in some diseases when body iron stores are not increased, as in acute and chronic liver damage,9 malignancy,'0 megaloblastic anaemia" and infections.
We have now studied the incidence of AA There was no significant difference between the AA-replete and AA-deficient patients with regard to either serum aminotransferase concentrations (p > 0 5) or the degree of iron overload as judged by the liver iron concentration (p > 0 5) (Table) . However, there was a tendency for the liver iron concentration and number of units transfused to be greater in the AA-deficient group (Table) . This was confirmed when a significant negative correlation (r = -033; p < 001) was observed between units of blood transfused and leucocyte AA concentrations.
In order to assess liver iron loading in relation to the units of blood transfused, a ratio was obtained by dividing the liver iron concentration by the number of units transfused (Table) . There was no difference in the mean ratios between AA-replete and deficient patients (p > 0-5).
SERUM FERRITIN A significant but weak correlation (r = 0-42; p < 0-005) was obtained between the serum ferritin and liver iron concentration in the 44 patients who had had liver biopsy (Fig. l) '2 patients, nine of whom had received more than 100 units of blood (Fig. 2) (Fig. 3) , although the mean rise was not The serum iron and percentage saturation of the Liver iron concentration (,ug/100mg dry weight) total iron binding capacity rose despite chelation Fig. 4 Serum ferritin plotted against liver iron in 13/15 and 11/13 respectively of patients after AA concentration in previously ascorbic acid deficient treatment (t test for paired samples p < 0-02 for patients after ascorbic acid repletion. both measurements). In contrast the serum iron and percentage saturation fell with chelation in 3/5 patients who were initially AA-replete (NS).
Discussion
This study has shown that ascorbic acid (AA) deficiency commonly occurs in P-thalassaemia major especially in the older and more transfused patients. These results are in keeping with previous studies of patients with idiopathic haemochromatosis,3 17trans-fusional iron overload3 and Bantu siderosis.2 It appears, therefore, that both primary or secondary iron overload commonly lead to AA deficiency. In Bantu patients with siderosis the depletion of the vitamin has been shown to be due to accelerated catabolism of ascorbic acid and this has been ascribed to the large amounts of ferric compounds in the tissues. 18 Ascorbate deficiency causes major abnormalities in human iron metabolism. We have confirmed that in iron-loaded AA-deficient thalassaemic patients, like siderotic Bantu,2 the serum iron is inappropriately low in relation to tissue iron stores and rises to appropriate concentrations with AA treatment. Ascorbate deficiency also leads to an increased concentration of haemosiderin and decreased ferritin content in cells.2 3 These changes can be rapidly reversed by the administration of AA. In the guinea pig, AA has been shown to be involved in the incorporation and release of iron from ferritin. 4 The results here show that in the presence of AA deficiency the serum ferritin concentration does not correlate with body iron stores, assessed by liver iron concentration or by units of blood transfused. The normally close correlation shown by Letsky et a!'9 can be restored by AA repletion. These inappropriate concentrations of serum ferritin in the AA-deficient group could not be ascribed to variation in liver damage, which is known to affect serum ferritin concentrations as the activities of aminotransferase were similar in the AA-deficient and replete patients.
The exact effect of AA therapy on serum ferritin concentration was difficult to assess since we commenced desferrioxamine chelation simultaneously with AA in all patients. This was essential in view of the suggested toxicity of AA therapy alone in iron-loaded thalassaemic patients. 20 Since desferrioxamine lowers serum ferritin in patients with thalassaemia major within a few months21 it was impossible, therefore, to elucidate the effect of AA therapy alone on serum ferritin in these patients.
In 
